Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cellceutix Licenses Drug From NYC Cancer Center | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cellceutix Licenses Drug From NYC Cancer Center

Has potential to treat illnesses associated with cancer

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cellceutix Corp. has signed a Confidential Disclosure Agreement with a leading research and cancer treatment center in New York City for the licensing of a novel compound with the potential to treat illnesses associated with cancer. The compound is not a drug for tumor regression and could create a new market for Cellceutix.
 
Cellceutix is a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics